Skip to main content

Voss Capital, LP

Position in XERS — Xeris Biopharma Holdings, Inc.

CIK 1730145 HOUSTON, TX

Position in XERS

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$8,044,176
+$5,126,261 QoQ
Shares Held
1,386,927
+273.1% QoQ
Ownership
0.761%
of shares outstanding
% of Portfolio
0.46%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2025
4 quarters on record
Voting authority Sole 87% Shared 0% None 13%

Common Shares in XERS Over Time

Shares Held

Position Value (USD)

Derivatives in XERS

reported options exposure · as of Mar 31, 2026
CallValue
$130,500
CallShares
22,500
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

All Filings in XERS

Export CSV
6 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $130,500 22,500
2026-03-31 $8,044,176 1,386,927
2025-12-31 $176,625 22,500
2025-12-31 $2,917,915 371,709
2025-06-30 $1,493,466 319,800
2025-03-31 $1,509,750 275,000